| Entry |
|
|---|
| Name |
Patisiran sodium (JAN);
Onpattro (TN)
|
|---|
| Product |
|
|---|
| Formula |
C412H480N148O290P40.40Na
|
|---|
| Exact mass |
14297.2775
|
|---|
| Mol weight |
14303.5785
|
|---|
| Sequence |
RNA: auggaauacu cuugguuact t
complex with RNA: guaaccaaga guauuccaut t |
|---|
| Type |
Nucleotide |
|---|
| Remark |
|
|---|
| Efficacy |
Gene expression regulator |
|---|
| Comment |
RNAi drug
Treatment of TTR mediated amyloidosis (ATTR)
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Transporters
Other transporters
Transthyretin
TTR
D10794 Patisiran sodium (JAN) <US>
New drug approvals in the USA [br08319.html]
New Molecular Entity and New Therapeutic Biological Product Approvals
D10794
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10794
 |
|---|
| Other DBs |
|
|---|
| LinkDB |
 |
|---|
